Clinical Application of Subxyphoid Approach Thoracoscopic Surgery in Thymoma Resection
10.3969/j.issn.1009-6604.2018.02.004
- VernacularTitle:经剑突下胸腔镜技术在胸腺瘤切除术中的应用
- Author:
Ke ZHANG
1
;
Jichun TONG
;
Qiyong WU
Author Information
1. 南京医科大学附属常州第二人民医院心胸外科
- Keywords:
Subxyphoid approach;
Video-assisted thoracoscopic surgery;
Thymoma
- From:
Chinese Journal of Minimally Invasive Surgery
2018;18(2):107-109
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical application of subxyphoid approach thoracoscopic surgery in thymoma resection. Methods The clinical data of 15 cases of mediastinal tumors receiving subxyphoid approach video-assisted thoracoscopic surgery from June 2015 to May 2017 were analyzed retrospectively.Among these cases,there were 6 male cases and 9 female cases, and the average age was(48.5 ±5.4)years old.There were 6 cases of thymoma with myasthenia gravis,including 5 cases of ocular myasthenia gravis and 1 case of mild systemic myasthenia gravis. Results All the 15 cases of operations were performed successfully without conversion to open surgery.The average operation time was(95 ±15)min, and average bleeding was(50 ±10)ml.The average hospital time was(4.2 ±1.5)days, and average thoracic cavity drainage time was(1.5 ±1.0)days.No postoperative complications occurred.Pathological reports showed that type A thymoma in 8 cases,type AB thymoma in 5 cases,type B1 thymoma in 1 case,and type B2 thymoma in 1 case.The mean follow-up time of all the 15 cases was(6.5 ±2.5)months, and no thymoma recurrence was seen.According to the Monden standard,muscle weakness symptoms disappeared in 5 cases and improved in 1 case in the 6 cases with myasthenia gravis. Conclusion Subxyphoid approach thoracoscopic thymoma resection is safe and feasible.
